You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design

Article metrics

Article menu
Original research
Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design

 

Online download statistics by month:

Online download statistics by month: July 2022 to March 2024

AbstractFullPdf
Jul 202213313931
Aug 202229830567
Sep 202218218624
Oct 202217818026
Nov 202213513517
Dec 20221421419
Jan 202312612715
Feb 202312212824
Mar 2023959510
Apr 2023353811
May 2023262614
Jun 202321228
Jul 202317176
Aug 2023333510
Sep 2023343713
Oct 2023404314
Nov 202337389
Dec 2023343427
Jan 2024222211
Feb 2024454612
Mar 2024414328
Total17961837386